InsiderClue
← All stocks

Aquestive Therapeutics, Inc.

AQST Balanced
CIK 0001398733 #3023 in the set updated 17 Sep 2026
Bought (120 mo)
$3.13M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$5.88M
$1.80M on a plan · $955.67K straight out of an exercise
Sold at will
$3.12M
17 of 35 sales
Net
−$2.75M
+$12.38K against sales at will

By person

23 insiders · 72 transactions
4.7×

Daniel Barber holds only 4.7 times base salary in stock. $3.14M of shares against $659.89K in salary for 2025.

Salary from the company's own proxy. The shares are what Daniel Barber last reported holding, valued at $4.82, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
BRATTON DOUGLAS K
10% owner
$2.48M (1)
—
+$2.48M
2,161,004
1.72%
$10.41M
−43.0%
Barber Daniel
President and CEO
$104.05K (3)
$1.77M (9) scheduled
−$1.67M
652,317
0.5197%
$3.14M
+714.7%
Schobel Alexander Mark
Chief Innovation/Tech Officer
$79.45K (4)
$1.62M (9)
−$1.54M
984,476
0.7844%
$4.74M
−2.4%
Jung Cassie
Chief Operating Officer
—
$975.90K (4) scheduled
−$975.90K
208,833
0.1664%
$1.01M
+502.6%
Boyd Peter E.
Chief People Officer
$13.53K (5)
$336.91K (4) scheduled
−$323.38K
284,024
0.2263%
$1.37M
+472.0%
TOTH A ERNEST JR
Chief Financial Officer
—
$243.09K (1)
−$243.09K
283,460
0.2258%
$1.37M
—
Kraus Carl N
Chief Medical Officer
—
$141.90K (1) scheduled
−$141.90K
282,475
0.2251%
$1.36M
—
Kendall Keith J
CEO and President
$121.18K (9)
$255.31K (1)
−$134.13K
639,149
0.5092%
$3.08M
+4.4%
Krop Julie
Director
—
$125.39K (1) scheduled
−$125.39K
0
0.0000%
$0.00
—
Maxwell John T.
SVP-Chief Financial Officer
$142.35K (2)
$24.00K (1)
+$118.35K
150,614
0.1200%
$725.88K
+8.7%
Korczynski Sherry
Chief Commercial Officer
—
$111.36K (2)
−$111.36K
235,689
0.1878%
$1.14M
+371.4%
Cioffi Melina
SVP, Regulatory Affairs
—
$105.62K (1)
−$105.62K
273,200
0.2177%
$1.32M
+49.9%
Scibetta James S
Director
$86.98K (3)
—
+$86.98K
31,635
0.0252%
$152.46K
+265.1%
BRAENDER LORI J
Corporate Secretary
$86.15K (4)
$167.35K (1)
−$81.19K
231,042
0.1841%
$1.11M
—
Marshall Ken W.
SVP, Chief Commercial Officer
$14.67K (1)
—
+$14.67K
151,445
0.1207%
$729.89K
—
Wood Theresa
SVP-HR and Org. Development
$9.16K (2)
—
+$9.16K
80,765
0.0643%
$389.25K
+1.9%
Wargacki Stephen
Chief Science Officer
—
—
—
343,552
0.2737%
$1.66M
+1,722%
Zalewski Thomas A.
Chief Legal Officer
—
—
—
100,000
0.0797%
$481.95K
—
Davis Matthew W.
Chief Development Officer
—
—
—
100,000
0.0797%
$481.95K
—
Cochran John
Director
—
—
—
99,486
0.0793%
$479.47K
+32.5%
BROWN GREGORY B
Director
—
—
—
75,085
0.0598%
$361.87K
0.0%
Greenhawt Matthew J.
Chief Medical Officer
—
—
—
75,000
0.0598%
$361.46K
—
COSTA SANTO J
Director
—
—
—
17,327
0.0138%
$83.51K
0.0%

Individual transactions

34
Insider
Date
Role
Action
Shares
Price
Amount
Boyd Peter E.
14 Jun 2022
SVP-Bus. Process & Info. Tech.
Buy
5,000
$0.81
$4.05K
BRAENDER LORI J
8 Jun 2022
General Counsel
Buy
13,761
$0.96
$13.21K
Boyd Peter E.
8 Jun 2022
SVP-Bus. Process & Info. Tech.
Buy
2,293
$0.96
$2.20K
Schobel Alexander Mark
8 Jun 2022
Chief Innovation/Tech Officer
Buy
45,871
$0.96
$44.04K
Barber Daniel
8 Jun 2022
Chief Executive Officer
Buy
91,743
$0.96
$88.07K
Boyd Peter E.
16 Mar 2020
SVP-Bus. Process & Info. Tech.
Buy
2,000
$1.50
$3.00K
BRAENDER LORI J
16 Mar 2020
SVP, General Counsel
Buy
14,000
$1.54
$21.62K
Barber Daniel
27 Aug 2019
SVP-Chief Operating Officer
Buy
2,000
$3.99
$7.98K
Scibetta James S
21 Aug 2019
Director
Buy
900
$3.81
$3.43K
Scibetta James S
20 Aug 2019
Director
Buy
11,310
$3.80
$43.00K
Scibetta James S
19 Aug 2019
Director
Buy
10,761
$3.77
$40.55K
Kendall Keith J
14 Aug 2019
CEO and President
Buy
1,000
$3.65
$3.65K
Kendall Keith J
14 Aug 2019
CEO and President
Buy
1,000
$3.70
$3.70K
Kendall Keith J
13 Aug 2019
CEO and President
Buy
1,000
$4.05
$4.05K
Boyd Peter E.
12 Aug 2019
SVP-Bus. Process & Info. Tech.
Buy
600
$3.81
$2.29K
BRAENDER LORI J
9 Aug 2019
SVP, General Counsel
Buy
10,000
$4.07
$40.75K
Wood Theresa
9 Aug 2019
SVP-HR and Org. Development
Buy
1,000
$3.99
$3.99K
Kendall Keith J
9 Aug 2019
CEO and President
Buy
2,000
$4.00
$7.99K
Kendall Keith J
9 Aug 2019
CEO and President
Buy
1,000
$3.93
$3.93K
Kendall Keith J
9 Aug 2019
CEO and President
Buy
2,000
$3.84
$7.68K
Barber Daniel
10 Dec 2018
SVP-Chief Strategy/Dev Officer
Buy
1,000
$8.00
$8.00K
Schobel Alexander Mark
10 Dec 2018
Chief Innovation/Tech Officer
Buy
1,000
$7.78
$7.78K
Maxwell John T.
6 Dec 2018
SVP-Chief Financial Officer
Buy
5,000
$8.87
$44.35K
Schobel Alexander Mark
6 Dec 2018
Chief Innovation/Tech Officer
Buy
2,000
$8.69
$17.38K
Kendall Keith J
27 Nov 2018
CEO and President
Buy
1,000
$9.87
$9.87K
BRAENDER LORI J
27 Nov 2018
General Counsel
Buy
1,000
$10.57
$10.57K
Wood Theresa
26 Nov 2018
SVP-HR and Org. Development
Buy
500
$10.34
$5.17K
Kendall Keith J
23 Nov 2018
CEO and President
Buy
1,950
$9.90
$19.31K
Kendall Keith J
21 Nov 2018
CEO and President
Buy
6,000
$10.17
$61.02K
Boyd Peter E.
21 Nov 2018
SVP-Operations/Value Delivery
Buy
200
$9.98
$2.00K
Maxwell John T.
21 Nov 2018
SVP-Chief Financial Officer
Buy
10,000
$9.80
$98.00K
Schobel Alexander Mark
21 Nov 2018
Chief Innovation/Tech Officer
Buy
1,000
$10.25
$10.25K
Marshall Ken W.
21 Nov 2018
Commercial Leader
Buy indirect
1,445
$10.15
$14.67K
BRATTON DOUGLAS K
24 Jul 2018
Director
Buy indirect
165,000
$15.00
$2.48M
Show all 72 transactions →

What was left out

Form 4 filings counted 282
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 4
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 11,683,907
Sales filed before the plan box existed 9
History held since 26 Jul 2018